These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15474859)

  • 1. New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA.
    Creticos PS; Chen YH; Schroeder JT
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):569-81, v. PubMed ID: 15474859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.
    Creticos PS; Lichtenstein LM
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):304-12; discussion 312-3. PubMed ID: 15119051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen immunotherapy in asthma: current status and future perspectives.
    Nagata M; Nakagome K
    Allergol Int; 2010 Mar; 59(1):15-9. PubMed ID: 20093852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy: 1999-2004.
    Norman PS
    J Allergy Clin Immunol; 2004 Jun; 113(6):1013-23; quiz 1024. PubMed ID: 15208577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE; Kline JN
    Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-based approaches to the treatment of allergies.
    Spiegelberg HL; Raz E
    Curr Opin Mol Ther; 2002 Feb; 4(1):64-71. PubMed ID: 11883696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-based immunotherapeutics for the treatment of allergic disease.
    Horner AA; Van Uden JH; Zubeldia JM; Broide D; Raz E
    Immunol Rev; 2001 Feb; 179():102-18. PubMed ID: 11292014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory sequences in immunotherapy.
    Blanks DA
    Curr Opin Otolaryngol Head Neck Surg; 2007 Aug; 15(4):281-5. PubMed ID: 17620904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-immunostimulatory oligodeoxynucleotide conjugate: a novel allergoid for immunotherapy.
    Spiegelberg HL; Horner AA; Takabayashi K; Raz E
    Curr Opin Allergy Clin Immunol; 2002 Dec; 2(6):547-51. PubMed ID: 14752340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen immunotherapy: where is it now?
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):769-79. PubMed ID: 17337297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis.
    Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC
    Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
    Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
    Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvants for immunotherapy.
    Pfaar O; Cazan D; Klimek L; Larenas-Linnemann D; Calderon MA
    Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):648-57. PubMed ID: 23090384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide immunotherapy for allergic diseases.
    Larché M
    Allergy; 2007 Mar; 62(3):325-31. PubMed ID: 17298351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvants for specific immunotherapy past, present, future.
    Drachenberg KJ
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):275-9; discussion 280-1. PubMed ID: 11487886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.